+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-Small Cell Lung Cancer KOL Interview - NH, US

  • PDF Icon

    Report

  • 10 Pages
  • August 2018
  • Region: United States
  • Citeline
  • ID: 4775202
Overview
The author interviewed a US-based oncologist with clinical trial and commercial experience of PD-1/L1 inhibitors to gauge his views on their current application within non-small cell lung cancer (NSCLC), and the potential broader development of immuno-oncology approaches and biomarkers within the indication.